Hiya, everybody, and the way are you in the present day? We’re doing simply high quality, thanks, particularly for the…
Read More
We’re studying about Novo Wegovy launch, ex-Pfizer exec’s subpoena
Prime of the morning to you. And a steamy one, it’s. In actual fact, there’s extra steam rising from the…
Read More
Novo Nordisk, seen as lagging in weight problems drug race, says it’s taking part in the lengthy sport
How did Novo Nordisk get to the place it’s in now — with its inventory halved over the previous 12…
Read More
Novo Nordisk drops Wegovy collaboration with Hims & Hers, alleges unsafe techniques
Add subject to e mail alerts Obtain an e mail when new articles are posted…
Read More
Compass, Vertex, Novo Nordisk, Gilead
Good morning! At this time, we get deeper into the ousting of Nicole Verdun on the FDA, see promise from…
Read MoreWe’re studying about Novo ending Hims deal, FDA transparency
Good morning, everybody, and welcome to a different working week. We hope the weekend respite was enjoyable and invigorating, as…
Read More
Novo Nordisk’s next-gen weight problems drug outcomes a letdown for buyers
CHICAGO — Late-stage outcomes of Novo Nordisk’s weight problems candidate CagriSema counsel the drug is akin to Eli Lilly’s Zepbound…
Read MoreWe’re studying about Novo Nordisk’s warning, FDA approvals
Good morning, everybody, and the way are you at this time? We’re doing simply wonderful, thanks, regardless of rising temperatures…
Read More
Novo Nordisk, Vigil, Merck, RegenxBio
Need to keep on high of the science and politics driving biotech as we speak? Enroll to get our biotech…
Read More
Novo Nordisk led the burden loss drug growth. Now it is catch-up time
Within the late 2010s, scientists on the Danish drugmaker Novo Nordisk developed a brand new weekly weight problems remedy that…
Read More
